Outcomes of patients (pts) treated with novel immunotherapy (IT) agents in phase 1 clinical trials (Ph1-CT) at early lines for advanced disease-MedSci.cn

Outcomes of patients (pts) treated with novel immunotherapy (IT) agents in phase 1 clinical trials (Ph1-CT) at early lines for advanced disease

Soto, JJ; Lecuona, CE; Serna, SL; Margalef, NM; Stradella, A; Villanueva, R; Campos, MC; Casulleras, MJ; Amor, CC; Soler, RS; Gil-Martin, M; Martin Liberal, J; Oliva, M

JOURNAL OF CLINICAL ONCOLOGY, 2022; 40 (16):

科室
- - 订阅+
  - 更多科室
工具
服务